• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

LifeScan releases latest version of diabetes management app

October 30, 2018 By Sarah Faulkner

LifeScan OneTouch appLifeScan said today that it released the latest version of its OneTouch Reveal mobile app. The digital tool is designed to help people with diabetes track their blood sugar levels using their mobile devices and share data with healthcare teams and caregivers.

The newest version of LifeScan’s app includes notifications that automatically warn users of recurring high or low patterns.

People using the app can also set goals, track their blood glucose history and log information like carbohydrate intake and number of steps taken. The OneTouch Reveal app can also show users their 90-day A1c average so they can monitor their blood sugar levels over time.

The app syncs via Bluetooth with the OneTouch Verio Flex blood glucose monitoring system. LifeScan touted the app as the most downloaded diabetes app in the U.S. and Canada since 2017.

Earlier this month, Johnson & Johnson (NYSE:JNJ) closed the $2.1 billion sale of its LifeScan subsidiary to private equity player Platinum Equity.

The sale was part of the healthcare giant’s move to get out of the device segment of the diabetes business. Last year J&J announced a strategic review of the LifeScan, Animas and Calibra Medical diabetes businesses, eventually deciding shutter the Animas insulin pump unit.

Want to stay on top of DDBN content? Sign up for our e-mail newsletter for a weekly dose of drug-device news.

Filed Under: Diabetes, Featured, Patient Monitoring, Wall Street Beat Tagged With: lifescan

IN CASE YOU MISSED IT

  • Senseonics stock is up on Q2 results
  • MedAlliance wins second FDA IDE nod for drug-coated balloon
  • Wells Fargo downgrades Tandem amid rise of automated insulin delivery competition
  • FDA approves first targeted infusion therapy for HER2-low breast cancer
  • Abbott, WeightWatchers partner on diabetes care

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Drug Delivery Business News in a minute? We Deliver!
Drug Delivery Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Signup for the newsletter

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing & Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts
Add us on FacebookFollow us on TwitterConnect with us on LinkedIn

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS